Hole Barnaby, Coast Joanna, Caskey Fergus J, Selman Lucy E, Rooshenas Leila, Kimpton George, Snead Charlotte, Field Amie, Morton Rachael L
Population Health, University of Bristol, Bristol, UK; Richard Bright Renal Unit, North Bristol NHS Trust, Westbury on Trym, UK.
Population Health, University of Bristol, Bristol, UK.
Kidney Int. 2025 Jan;107(1):130-142. doi: 10.1016/j.kint.2024.08.032. Epub 2024 Oct 4.
Most older people with kidney failure choose between treatment with dialysis or conservative kidney management. The preferences underlying these decisions are poorly understood. Here, we performed a choice experiment, informed by qualitative research, to examine preferences for the characteristics of dialysis and conservative management among over-65-year-olds with eGFR of 20 mls or under/min/1.73m. Mixed logit and latent class analyses quantified the trade-offs between frequency and location of treatments, survival, and capability (the ability to do important activities), accounting for participants' characteristics. Overall, 327 United Kingdom participants across 23 centers (median age 77 years, eGFR 14 mls/min/1.73m ) needed 8%-59% absolute survival benefit two years after starting treatment to accept dialysis, with preferences for less frequent treatment and treatment at home. Significantly higher preferences for survival were seen amongst partnered participants (effect size 0.04, 95% confidence interval 0.02-0.06) and if better levels of capability were depicted (effect size 0.02, 0.01-0.03). Three latent classes were identified with divergent preferences for survival, capability, and location of care. Stated preferences indicated participants favored higher survival probabilities, but only if their capability was preserved and the location and frequency of care were acceptable. Subgroups may prioritize survival, hospital avoidance, or in-center care. Clinicians supporting people making kidney failure treatment decisions must explore their goals and values. Thus, investment in services that prioritize capability and ensure treatment is delivered at a frequency acceptable to people in their preferred location would enable provision of preference sensitive care.
大多数老年肾衰竭患者需要在透析治疗和保守肾脏管理之间做出选择。这些决策背后的偏好尚不清楚。在此,我们在定性研究的基础上进行了一项选择实验,以研究65岁以上估算肾小球滤过率(eGFR)为20毫升或更低/分钟/1.73平方米的患者对透析和保守治疗特征的偏好。混合逻辑回归和潜在类别分析量化了治疗频率和地点、生存率以及能力(进行重要活动的能力)之间的权衡,并考虑了参与者的特征。总体而言,来自英国23个中心的327名参与者(中位年龄77岁,eGFR为14毫升/分钟/1.73平方米)在开始治疗两年后需要8%-59%的绝对生存获益才会接受透析,他们更倾向于治疗频率较低且在家中进行治疗。在有伴侣的参与者中(效应量0.04,95%置信区间0.02-0.06)以及如果描绘出更好的能力水平时(效应量0.02,0.01-0.03),对生存的偏好明显更高。确定了三个潜在类别,它们对生存、能力和护理地点有不同的偏好。表明的偏好表明参与者更倾向于更高的生存概率,但前提是他们的能力得以保留且护理地点和频率是可接受的。亚组可能会优先考虑生存、避免住院或中心护理。支持肾衰竭患者做出治疗决策的临床医生必须探究他们的目标和价值观。因此,投资于优先考虑能力并确保在患者首选地点以可接受的频率提供治疗的服务,将能够提供符合偏好的护理。